Abstract
Most patients with postanoxic myoclonus (PAM) have poor outcomes; consequently, prognostication studies have largely focused on identifying patients with little chance of recovery.1 Recent studies, however, show that about 9% of patients with PAM have favorable outcomes.2 Until now, there have been limited clinical methods to identify these patients.3,4 A major difficulty is that many of the treatments used to treat hypoxic-ischemic coma, such as therapeutic hypothermia and antiseizure treatment, may interfere with patients' neurophysiologic tests and clinical evaluations.5,7
| Original language | English (US) |
|---|---|
| Pages (from-to) | 149-150 |
| Number of pages | 2 |
| Journal | Neurology |
| Volume | 95 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 28 2020 |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint
Dive into the research topics of 'MRI and EEG accurately classify favorable prognosis for patients with postanoxic myoclonus: Paradigm shift'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS